Literature DB >> 9345047

Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain.

L Genestier1, R Paillot, N Bonnefoy-Berard, G Meffre, M Flacher, D Fèvre, Y J Liu, P Le Bouteiller, H Waldmann, V H Engelhard, J Banchereau, J P Revillard.   

Abstract

In addition to their major function in antigen presentation and natural killer cell activity regulation, HLA class I molecules may modulate T-cell activation and proliferation. Monoclonal antibodies (MoAbs) that recognize distinct epitopes of HLA class I molecules were reported to interfere with T-cell proliferation. We show here that two MoAbs (mouse MoAb90 and rat YTH862) that bind to an epitope of the alpha1 domain of HLA class I heavy chain induce apoptotic cell death of activated, but not resting, peripheral T lymphocytes. Other reference anti-HLA class I antibodies specific for distinct epitopes of the alpha1 (B9.12.1), alpha2 (W6/32), or alpha3 (TP25.99) domains of the heavy chain decreased T-cell proliferation but had little or no apoptotic effect. Apoptosis shown by DNA fragmentation, phosphatidylserine externalization, and decrease of mitochondrial transmembrane potential was observed whatever the type of T-cell activator. Apoptosis did not result from Fas/Fas-L interaction and distinct though partly overlapping populations of activated T cells were susceptible to Fas- and HLA class I-mediated apoptosis, respectively. Induction of apoptosis did not require HLA class I cross-linking inasmuch as it could be observed with monovalent Fab' fragments. The data indicate that MoAb90 and YTH862 directed against the alpha1 domain of HLA class I trigger apoptosis of activated T lymphocytes by a pathway which does not involve Fas-ligand.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345047

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms.

Authors:  G Kovalev; K Duus; L Wang; R Lee; M Bonyhadi; D Ho; J M McCune; H Kaneshima; L Su
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 2.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

3.  Novel cellular microarray assay for profiling T-cell peptide antigen specificities.

Authors:  C Yue; M Oelke; M E Paulaitis; J P Schneck
Journal:  J Proteome Res       Date:  2010-10-04       Impact factor: 4.466

4.  HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells.

Authors:  Stefania Lenna; Danyelle M Townsend; Filemon K Tan; Bagrat Kapanadze; Malgorzata Markiewicz; Maria Trojanowska; Raffaella Scorza
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

5.  Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.

Authors:  L Genestier; R Paillot; S Fournel; C Ferraro; P Miossec; J P Revillard
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

6.  A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.

Authors:  Shuji Matsuoka; Hiromichi Tsurui; Masaaki Abe; Kazuo Terashima; Kazuhiro Nakamura; Yoshitomo Hamano; Mareki Ohtsuji; Nakayuki Honma; Isao Serizawa; Yasuyuki Ishii; Masafumi Takiguchi; Sachiko Hirose; Toshikazu Shirai
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

7.  Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.

Authors:  Shuji Matsuoka; Yasuyuki Ishii; Atsuhito Nakao; Masaaki Abe; Naomi Ohtsuji; Shuji Momose; Hui Jin; Hisashi Arase; Koichi Sugimoto; Yusuke Nakauchi; Hiroshi Masutani; Michiyuki Maeda; Hideo Yagita; Norio Komatsu; Okio Hino
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.